Back to mobile site

AbbVie (ABBV): Pipeline Confidence Weakening - BMO

April 20, 2017 6:37 AM EDT Send to a Friend
BMO Capital analyst, Alex Arfei, reiterated his Market Perform rating on shares of Abbvie (NYSE: ABBV) after a the company ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login